U.S. Congress - H.Con.Res.342 Expressing the sense of Congress that the Food and Drug Administration's (FDA) new poli...
H.Con.Res.342 - Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
view all titles (1)All Bill Titles
- Official: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Vote on This Bill
-
Share This Bill
More Share via Email
Sort By
Comments Feed
I have been taking estriol for nearly 4 years and my sister for more than 5 years. We both have multiple sclerosis and estriol was shown in a small study, to decrease the number of new lesions and improve the cognitive function in those patients with MS. Now their is a new clinical study beginning to test estriol alongside the MS drug copaxone. My sister can no longer get her estriol and is not eligible for the new clinical trial. I have applied for the clinical trial, but I am unsure if I will be accepted. I think it’s criminal to disregard the health of MS patients who are currently taking estriol, the safest of ALL the estrogens, for the sake of big Pharma. Please pass this bill!!
This is unbelievable, wait till they try to take estriol away from the european women!
We better fight hard and fast to get them to support our use of natural hormones.